The latest credit push for the pandemic-hit sectors and other relief supports will have an additional 60 bps impact on the fiscal deficit, and can offer an additional liquidity window of Rs 70,000 crore to banks, says a report.
Finance minister Nirmala Sitharaman on Monday announced Rs 1.5 lakh-crore of additional credit for small businesses, more funds for the healthcare sector, loans to tourism agencies and guides, and waiver of visa fees as part of a credit-led package to support the pandemic-hit economy.
The package, mostly made up of government guarantees to banks and microfinance institutions for loans they extend to the pandemic-hit sectors, totals up to Rs 6.29 lakh crore together with the previous such packages.
Assuming equal distribution of the new announcement of Rs 1.10 lakh crore, with 50 per cent and 75 per cent guarantee cover and a risk weight of 100 per cent, banks may have a capital relief of around Rs 7,500 crore that can further generate credit of around Rs 70,000 crore, according to an SBI Research analysis.
The fiscal impact of latest announcements and earlier is not linear as a substantial portion of the package is contingent liabilities. Ignoring these, the immediate impact will be slightly over Rs 1.23 lakh crore which will be around 0.6 per cent of the GDP, SBI chief economist Soumya Kanti Ghosh said in the report.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Monday's announcement broadly emphasises four sectors – health, tourism, MFIs and agriculture. The other measures announced fine-tune the scope of the already existing arrangements, he said.
Under the credit guarantee schemes to further the flow of credit to the weaker sections of the society, guarantees will be provided to banks for loans to new or existing NBFC-MFIs or MFIs for lending up to Rs 1.25 lakh to around 25 lakh small borrowers. Interest rate on such loans will be capped at MCLR plus 2 per cent.
Though most of the latest announcements are part/extension of the past packages, overall, this is a timely relief to the sectors/segments that were impacted most by the second wave of the pandemic.
The Rs 50,000-crore guarantee cover package to boost the medical infrastructure in underserved areas across the 124 aspirational districts, can lead to the overall improvement in human development, the report said.
At present, as per MSME website, 124 districts are recognised as aspirational districts. Maximum loan size under the scheme is kept at Rs 100 crore with interest rate cap of 7.95 per cent and guarantee duration of three years.